France's Sanofi buys biotech company Ablynx for $4.8 billion

French drugmaker Sanofi has made another big purchase aimed at strengthening its position in rare disease treatments, buying Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion)
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news